Skip to content

Clinical trials

Active, not recruiting Breast Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Active, not recruiting Country / region: Germany Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20145
20154
20161
20174
20186
20193
20208
202115
202210
20239
20245
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting75

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca14
Eli Lilly and Company8
Hoffmann-La Roche8
Novartis Pharmaceuticals4
Pfizer4
MedSIR3
Seagen, a wholly owned subsidiary of Pfizer3
Alliance Foundation Trials, LLC.2
Merck Sharp & Dohme LLC2
University Hospital, Basel, Switzerland2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms75
Neoplasm Metastasis9
Neoplasms6
Carcinoma, Non-Small-Cell Lung4
Neoplasms by Site4
Brain Neoplasms3
Breast Diseases3
Head and Neck Neoplasms3
Thyroid Cancer, Papillary3
Bronchial Neoplasms2

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.